Cour Pharmaceuticals Development Co., Inc.’s Post

Our 2nd East-West Biopharma Summit is scheduled for Oct. 2-4 in Boston/Cambridge. Register at: https://lnkd.in/ePrt_pnf A few highlights: ➤ The program will focus on global development strategies, including how to extend your cash runway or fill your pipeline via cross-border collaborations. ➤ Speakers include: Christopher Viehbacher of Biogen; Andy Plump of Takeda, Robert Plenge of Bristol Myers Squibb; Christiana Bardon M.D. of MPM BioImpact, Rachel Mears of JEITO, Mathai Mammen, M.D., Ph.D. of FogPharma, Paul Peter Tak, MD PhD FMedSci of Candel Therapeutics, Jason Radford of BeiGene, Alex Zhavoronkov of Insilico Medicine, Christopher Mortko of Merck, Dr. Shanshan Xu of BioNTech SE, Vishal Doshi of AUM Biosciences, Paula Soteropoulos of 5AM Ventures, Raymond Pawlicki of PrecisionLife, Christine Aylward of Magnetic Ventures, Arjen Lemmen of argenx and more. ➤ 40+ presenting companies including: Boston Pharmaceuticals, Inmagene Biopharmaceuticals, Neuraly Inc., Oculis and Spotlight Therapeutics. Full list: https://lnkd.in/gVrJXwj6 ➤ Exclusive conference report from Insights Partner McKinsey & Company: Will #AI save the day for global #biotech? ➤ One-to-one partnering and C-level networking. This is the place to find your next cross-border partner or investor. We expect many China and Asia biotech execs to be in the room in Boston. ➤ Special discounts available for BioCentury Inc. subscribers and members of BayHelix or MassBio. Please send a DM if you'd like to know more. We hope to see you next month in Kendall Square! #biopharma #drugdevelopment #venturecapital #dealmaking

Exciting insights unveiled in BioTalk Unzipped Episode 3! 🎙️ Join hosts Gregory Austin and Dr. Chad Briscoe as they delve into the dynamic world of biotech with the esteemed Dr. Russell Weiner. With over 30 years of hands-on experience, Dr. Weiner shares invaluable insights into biopharmaceuticals, clinical trials, and project leadership. Key Highlights: 🔬 **Professional Journey**: Explore Dr. Weiner's impressive career in the biopharmaceutical industry. 🌟 **What Inspired Him**: Uncover the motivations behind Dr. Weiner's distinguished biotech career. 🏥 **Hospice Success**: Discover a notable success story and its impact on Dr. Weiner's journey. 🔄 **Changes in 30 Years**: Trace the pivotal shift into biologics and dynamic industry changes. 🌐 **Biologics Challenges**: Dr. Weiner discusses current hurdles, from pre-analytics to logistics. 🦠 **COVID's Impact**: Gain insights into the pandemic's influence on biotech processes. 🌦️ **Weather's Effect**: Explore how weather conditions impact scientific processes. 🤝 **Improved Communication**: Reflect on enhanced communication in the biotech ecosystem. 🏗️ **Transformational Leadership**: Uncover Dr. Weiner's role as a lab builder and transformational leader. 👥 **Cohesive Lab Teams**: Insights into building successful and cohesive lab teams. 🌟 **Success Tips for Young Leaders**: Valuable advice for aspiring leaders in the dynamic field of biotech. 🏢 **Career at Takeda**: Explore Dr. Weiner's impactful career at Takeda Oncology and his strategies for team support. Tune in for a captivating journey through the evolving landscape of biotech! 🌐 #Biotech #Leadership #Innovation

How do CEOs of CDMOs navigate uncertainty and drive growth? Find out during the 2nd Annual Bioprocessing Venture, Innovation & Partnering Conference on August 21, 2024, in Boston, MA, part of CHI's Bioprocessing Summit. Hear from this all-star panel featuring industry leaders as they share their experiences, perspectives, and foresight on steering their organizations through dynamic and complex business landscapes to achieve sustainable growth and industry leadership. Ran Zheng (CEO, Landmark Bio) Steve Favaloro (President & CEO, Genezen) Patrick Lucy (President & CEO, RoslinCT) Rahul Singhvi (Co-Founder & CEO, Resilience) Gain insights into strategies for navigating market volatility, balancing short-term pressures with long-term goals, overcoming regulatory challenges, leveraging technology for innovation, and fostering resilience within organizations. Don’t miss this opportunity to connect with key players driving the future of bioprocessing. For more details, visit https://lnkd.in/gzryU8G2 #bioprocessing #innovation #biotech #conference #partnerships #CDMO #CEO

Highlights from the recent Executive Interviews at Fierce Biotech Summit and New Product Planning 2023! 🚀 Dive into these thought-provoking articles featuring conversations with prestigious leaders in the field. Gain valuable insights into the latest trends and innovations shaping the future of biotech and digital marketing. Link to main article: https://lnkd.in/gPWbA2z4 #FierceBiotechSummit #FierceNPP #LeadershipInsights #ExecutiveInterview #WeAreFierce #biotech

“Life sciences organizations have got to prioritize bringing in the right level of leadership at the right stage of the business development to establish this proper technology layer.” In part two of this Q&A with Robert Burke, Benchling’s GM of EMEA, and Jason C. Foster, founder of Ori Biotech, the #biotech leaders explain how technological development can deliver life-changing data insights. https://lnkd.in/e86GuyxU

Enveda Biosciences Secures $55 Million In New Financing Round Learn more & get our take 👇 https://lnkd.in/d_-e9QfD “At Premji Invest, we seek to partner with exceptional teams to build companies that can create long-term value. We are excited by Enveda’s potential to deliver new, safe and efficacious treatments for complex conditions, pushing the boundaries of AI and ML in life sciences.” — Sandesh Patnam, Managing Partner at Premji Invest “We’re proud to support Enveda as we see its potential for long-term, open-ended growth due to the broad utility of their technology for solving some of the toughest challenges facing human and planetary health.” — Morgan Samet, Partner and Co-Head at Lingotto Investment Management “The investors who joined in this round recognize our rapid progress, as well as our expansive potential and vision. In combination with our deep bench of top tier investors, we are in an ideal position to advance our novel medicines into the clinic and to bring hope to waiting patients.” — Viswa Colluru, PhD, Ph.D., CEO and Founder at Enveda #funding #biosciences #SoHCNews

Interesting in learning more about how our team can connect your team to biopharma companies making new advancements? Check out this recent webinar if so! During a webinar presented with IN-PART, Karmen Trzupek, Senior Director of Scientific Programs, shared how their platform at RARE-X can combine innovation priorities to propel academia, industry R&D, and biotechs to collaboration. To catch the recording, click here: https://hubs.li/Q01_XwvQ0

You’re considering attending, but concerned your English skills aren't good enough? It's not too late to do something about it. Hi, I'm Louise and I help executives and scientists overcome their fear of speaking and networking in English so that they can relax and actually enjoy taking part in online and in person events. I have over 25 years experience as a language trainer working predominantly with clients from the pharmaceutical industry and specialise in helping people overcome their anxiety when speaking English. DM me to find out how I can help you. #pharma #pharmaceticalindustry #languagebarriers #businessenglish  #sciencenews #biotechnologie  #englishtalk

🌐 Innovation Beyond Boundaries! 🚀 Dive into the stories of successful university/corporate collaborations that define the MSU Innovation Center's journey in 2023. Click the link below to read how MSU's and Takeda’s research partnership is leading to possible new therapeutics for Parkinson’s Disease: http://spr.ly/6048TaBus

Every time I hear Aviv speak, I learn more. “Lab in the loop” is how we will exponentially increase the rate of discovery.